Background Cigarette smoking is a major risk factor for the development and progression of cardiovascular disease. While smoking is associated with increased levels of inflammatory markers and accelerated atherosclerosis, few studies have examined the impact of smoking cessation on levels of inflammatory markers. The degree and rate at which inflammation subsides after smoking cessation are uncertain. It also remains unclear as to whether traditional risk factors can adequately explain the observed decline in cardiovascular risk following smoking cessation. Methods and Findings Using data from 15,489 individuals who participated in the Third National Health and Nutrition Examination Survey (NHANES III), we analyzed the association between smoking and smoking cessation on levels of inflammatory markers and traditional cardiovascular risk factors. In particular, we examined changes in C-reactive protein, white blood cell count, albumin, and fibrinogen. Inflammatory markers demonstrated a dose-dependent and temporal relationship to smoking and smoking cessation. Both inflammatory and traditional risk factors improved with decreased intensity of smoking. With increased time since smoking cessation, inflammatory markers resolved more slowly than traditional cardiovascular risk factors. Conclusion Inflammatory markers may be more accurate indicators of atherosclerotic disease. Inflammatory markers returned to baseline levels 5 y after smoking cessation, consistent with the time frame associated with cardiovascular risk reduction observed in both the MONICA and Northwick Park Heart studies. Our results suggest that the inflammatory component of cardiovascular disease resulting from smoking is reversible with reduced tobacco exposure and smoking cessation.
引用
收藏
页码:528 / 536
页数:9
相关论文
共 61 条
[1]
ABERG A, 1983, BRIT HEART J, V49, P416, DOI 10.1136/hrt.49.5.416
[2]
Ablij H C, 2003, Ned Tijdschr Geneeskd, V147, P15
机构:
Univ Calif San Francisco, Div Pharmacol & Expt Therapeut, San Francisco, CA 94143 USAUniv Calif San Francisco, Div Pharmacol & Expt Therapeut, San Francisco, CA 94143 USA
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Blaschke, F
Bruemmer, D
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Bruemmer, D
Yin, F
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Yin, F
Takata, Y
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Takata, Y
Wang, W
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Wang, W
Fishbein, MC
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Fishbein, MC
Okura, T
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Okura, T
Higaki, J
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Higaki, J
Graf, K
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Graf, K
Fleck, E
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Fleck, E
Hsueh, WA
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USAUniv Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Hsueh, WA
Law, RE
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
机构:
Univ Calif San Francisco, Div Pharmacol & Expt Therapeut, San Francisco, CA 94143 USAUniv Calif San Francisco, Div Pharmacol & Expt Therapeut, San Francisco, CA 94143 USA
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Blaschke, F
Bruemmer, D
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Bruemmer, D
Yin, F
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Yin, F
Takata, Y
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Takata, Y
Wang, W
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Wang, W
Fishbein, MC
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Fishbein, MC
Okura, T
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Okura, T
Higaki, J
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Higaki, J
Graf, K
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Graf, K
Fleck, E
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Fleck, E
Hsueh, WA
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USAUniv Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
Hsueh, WA
Law, RE
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA